Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Baricitinib works better than methotrexate for severe alopecia areata.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib helped a woman regrow hair with no major side effects.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The combination treatment showed a higher response rate but no significant survival benefits.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Lecithin microemulsion safely delivers tetracaine hydrochloride through the skin.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Etanercept effectively treated a severe skin condition when other treatments failed.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.